METHODS: The prospective cohort study comprised 149 consecutive patients with solid
pancreatic lesions who underwent endoscopic ultrasound-guided fine-needle aspiration …

Objectives The accuracy of endoscopic ultrasound-fine needle aspiration cytology (EUS-
FNAC) for the diagnosis of pancreatic cancer is suboptimal. Mutational activation of the kras …

Objectives Endoscopic ultrasound-guided fine-needle aspiration (EUS-FNA) cytology was
one of the investigations for pancreatic masses. While the specificity approached 100%, its …

Aims In cystic and solid pancreatic lesions, KRAS mutational status refines the diagnosis of
uncertain endoscopic ultrasound (EUS) aspirates. This test should have a fast turnaround …

Endoscopic ultrasound-guided fine-needle aspiration (EUS-FNA) is the procedure of choice
for the cytologic diagnosis of pancreatic masses. The specificity of EUS-FNA approaches …

Background: The impact of KRAS mutation testing on pancreatic ductal adenocarcinoma
(PDAC) samples by endoscopic ultrasound-guided fine-needle aspiration (EUS-FNA) for …

Background/Aim: Detection of pancreatic cancer using small samples of the pancreas
obtained by endoscopic ultrasound-guided fine-needle aspiration (EUS-FNA) remains a …

Abstract Background or Purpose Pancreatic ductal adenocarcinoma (PDAC) is commonly
diagnosed by endoscopic ultrasound-guided fine needle aspiration (EUS-FNA). However …

OBJECTIVES: Endoscopic ultrasound-guided fine-needle aspiration biopsy (EUS-FNAB) is
a useful tool in the diagnosis of pancreatic masses. Genetic analysis of these samples could …

Results: Inconclusive or doubtful (low-grade dysplasia or atypia) cytopathology was found in
68 cases. Of these, 29 patients who had adenocarcinoma were subsequently diagnosed …